GILBERTO SANCHEZ: Open Payments
NPI 1588159628 · BENNETTSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 65 payments from 17 companies in 2025. Trend: 2023 $536 · 2024 $611 · 2025 $1,225
Food & beverage: $1,225
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $310 |
| AstraZeneca Pharmaceuticals LP | 12 | $199 |
| GlaxoSmithKline, LLC. | 6 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $92 |
| Merck Sharp & Dohme LLC | 5 | $82 |
| Novo Nordisk Inc | 3 | $73 |
| Corcept Therapeutics | 3 | $56 |
| Lundbeck LLC | 2 | $40 |
| Exact Sciences Corporation | 2 | $37 |
Products named: VRAYLAR, AIRSUPRA, TRELEGY ELLIPTA, CAPLYTA, Kerendia, VERQUVO, REXULTI, FARXIGA.
Industry payments across SC — which companies pay providers there.
